TickerFiles

Barinthus Biotherapeutics plc. 10-K filing

Filed 2026-03-13 · Report date 2025-12-31 · 2025 FY

View Original SEC Filing

Filing metadata

Accession number
0001828185-26-000012
Form type
10-K
CIK
0001828185
Primary document
https://www.sec.gov/Archives/edgar/data/1828185/000182818526000012/brns-20251231.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Barinthus Biotherapeutics plc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$0--
Operating Income$-70.6M--
Net Income$-66.4M--
Eps Basic-1.64--
Eps Diluted-1.64--
Cash And Equivalents$70.5M--
Total Assets$98.2M--
Total Liabilities$23.9M--
Shareholders Equity$74.2M--
Operating Cash Flow$-48.0M--
Capital Expenditures$37,000--